| Literature DB >> 27296664 |
Seung-Chul Choi1, Tarun E Hutchinson1, Anton A Titov1, Howard R Seay1, Shiwu Li1, Todd M Brusko1, Byron P Croker1, Shahram Salek-Ardakani1, Laurence Morel2.
Abstract
Pbx1 controls chromatin accessibility to a large number of genes and is entirely conserved between mice and humans. The Pbx1-d dominant-negative isoform is more frequent in CD4(+) T cells from lupus patients than from healthy controls. Pbx1-d is associated with the production of autoreactive T cells in mice carrying the Sle1a1 lupus-susceptibility locus. Transgenic (Tg) expression of Pbx1-d in CD4(+) T cells reproduced the phenotypes of Sle1a1 mice, with increased inflammatory functions of CD4(+) T cells and impaired Foxp3(+) regulatory T cell (Treg) homeostasis. Pbx1-d-Tg expression also expanded the number of follicular helper T cells (TFHs) in a cell-intrinsic and Ag-specific manner, which was enhanced in recall responses and resulted in Th1-biased Abs. Moreover, Pbx1-d-Tg CD4(+) T cells upregulated the expression of miR-10a, miR-21, and miR-155, which were implicated in Treg and follicular helper T cell homeostasis. Our results suggest that Pbx1-d impacts lupus development by regulating effector T cell differentiation and promoting TFHs at the expense of Tregs. In addition, our results identify Pbx1 as a novel regulator of CD4(+) T cell effector function.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27296664 PMCID: PMC4935607 DOI: 10.4049/jimmunol.1502283
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422